FDA Drug Safety Communication: Tysabri
The U.S. Food and Drug Administration (FDA) continues to evaluate the risk of progressive multifocal leukoencephalopathy ( PML ), a rare but serious brain infection, associated with use of Tysabri ( natalizumab ) for the treatment of multiple sclerosis (MS) and Crohn's disease.
Brain Disease Caused by Chronic Stress
Scientists have long linked chronic stress to brain degeneration. Now they may have identified the connection. These findings could ultimately aid in understanding and treating Alzheimer's disease.
New Genetic Clues About Rare Brain Disorder
Progressive supranuclear palsy is a rare and devastating disease with no known treatments. New genetic clues could provide new insights into neurodegenerative therapies.
Multiple Sclerosis - Tricky, Unpredictable, Incurable
When a friend asked Kimberly Zolotar what it was like having Multiple Sclerosis (MS), she couldn't immediately answer. Sharing her thoughts in the "My Turn" section of the Los Angeles Times , Kimberly wrote in 2008, "How could I possibly explain how it feels to have a potentially disabling, progressive and incurable neurological disease? It has been 13 years since my doctor told me I have MS, but the answer to my friend's question changes every day, sometimes every hour."